Private Wealth Management Group, LLC Acadia Pharmaceuticals Inc Transaction History
Private Wealth Management Group, LLC
- $231 Billion
- Q2 2024
A detailed history of Private Wealth Management Group, LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Private Wealth Management Group, LLC holds 63 shares of ACAD stock, worth $1,012. This represents 0.0% of its overall portfolio holdings.
Number of Shares
63
Previous 43
46.51%
Holding current value
$1,012
Previous $796,000
28.64%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ACAD
# of Institutions
288Shares Held
161MCall Options Held
723KPut Options Held
257K-
Baker Bros. Advisors LP New York, NY42.9MShares$689 Million9.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.7MShares$220 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY13.7MShares$220 Million3.72% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$194 Million0.0% of portfolio
-
State Street Corp Boston, MA5.8MShares$93.2 Million0.0% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $2.6B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...